Vaping products, including e-cigarettes and e-liquids, are under scrutiny for their potential link to lung cancer. While research findings are still evolving, there is concern based on molecular science that these products could pose oncogenic risks.
Given the possible long latency period of up to 20 years, further studies are essential to understand the true impact of vaping on lung health. Meanwhile, tighter regulation may be advisable to mitigate potential future health issues.